0001209191-20-000404.txt : 20200102 0001209191-20-000404.hdr.sgml : 20200102 20200102173240 ACCESSION NUMBER: 0001209191-20-000404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191230 FILED AS OF DATE: 20200102 DATE AS OF CHANGE: 20200102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liang Hong CENTRAL INDEX KEY: 0001754627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 20502489 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-30 0 0001468748 Kodiak Sciences Inc. KOD 0001754627 Liang Hong 2631 HANOVER ST. PALO ALTO CA 94304 0 1 0 0 SVP, Discovery Medicine Stock Option (Right to Buy) 73.51 2019-12-30 4 A 0 50000 0.00 A 2029-12-29 Common Stock 50000 50000 D 1/48th of the shares subject to the option will vest on January 30, 2020, and 1/48th of the shares subject to the option vest on the same day of each month thereafter, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) as of each such date. /s/ Carlton Fleming, Attorney-in-fact for Hong Liang 2020-01-02